Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trialsYangxun Pan, Zhongguo Zhou, Li Xu et al.|Frontiers in Bioscience-Landmark|2021Cited by 19
Stereotactic body radiotherapy vs radiofrequency ablation in the treatment of hepatocellular carcinoma: a meta-analysisYangxun Pan, Yaojun Zhang, Long Qian et al.|Research Square|2019Cited by 2
ASO Visual Abstract: Comparison between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate/Advanced-Stage Hepatocellular CarcinomaYangxun Pan, Li Xu, Rong Guo et al.|Annals of Surgical Oncology|2021Cited by 0